BBVA BBVA
Company Profile ↓Company Overview
BBVA (BBVA) is a publicly traded company listed on with a market capitalization of $160.25B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 18.3%, reflecting efficient use of shareholder capital.
Net profit has compounded at 18.2% per year over the last five years.
Revenue has grown at a 12.0% CAGR over the past five years.
Trades at an undemanding P/E of 15.9.
Maintains a net profit margin of 26.7%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $39.41B (+0.5% YoY); net profit $10.51B.
- Trailing 12 Months Year-on-year growth — revenue +0.5%, earnings +4.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 12.0%, profit CAGR 18.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 11.99% |
| 1 Year: | 0.46% |
Compounded Profit Growth
| 5 Years: | 18.24% |
| 1 Year: | 4.55% |
Stock Price Performance
| 1 Year: | +72.79% |
| 6 Months: | +12.85% |
| 3 Months: | +31.23% |
| 1 Month: | +7.67% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)66.10 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 26.7%.
- Compounding revenue at 12.0% over 5 years.
- Profit CAGR of 18.2% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 8.71B | 9.78B | 9.79B | 10.65B | 10.51B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| Interest Expense | 8.32B | - | 8.12B | - | - | - |
| Pretax Income | - | 4.08B | 3.87B | 3.93B | 4.72B | 4.86B |
| Tax Provision | - | 1.16B | 1.21B | 1.27B | 1.53B | 1.58B |
| Net Income | - | 2.75B | 2.53B | 2.53B | 2.99B | 3.06B |
| Diluted EPS | - | 0.46 | 0.42 | 0.42 | 0.51 | 0.53 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 28.07B | 33.43B | 39.23B | 39.41B |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | - | - | - | - |
| Operating Income | - | - | - | - |
| EBITDA | - | - | - | - |
| Interest Expense | 12.31B | 24.76B | 36.39B | 32.06B |
| Pretax Income | 10.27B | 12.42B | 15.40B | 16.23B |
| Tax Provision | 3.50B | 4.00B | 4.83B | 5.10B |
| Net Income | 6.36B | 8.02B | 10.05B | 10.51B |
| Diluted EPS | 0.98 | 1.29 | 1.68 | 1.76 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 712.09B | 775.56B | 772.40B | 859.58B |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 84.25B | 81.26B | 59.88B | 69.89B |
| Inventory | - | - | - | - | - |
| Receivables | 19.52B | 25.99B | 25.10B | 31.69B | - |
| Total Liabilities | - | 661.57B | 720.29B | 712.39B | 797.78B |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | 58.72B | 72.69B | 74.46B | 87.84B |
| Total Debt | - | 60.12B | 74.19B | 75.93B | 89.30B |
| Total Equity | - | 46.90B | 51.70B | 55.65B | 57.35B |
| Shares Outstanding | - | 6.03B | 5.84B | 5.76B | 5.71B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 23.72B | -721.00M | -18.19B | 14.97B |
| Investing Cash Flow | -3.91B | -1.42B | -1.42B | -1.40B |
| Financing Cash Flow | -7.56B | -1.84B | -2.57B | -3.67B |
| Capital Expenditure | -2.44B | -1.82B | -2.01B | -1.81B |
| Free Cash Flow | 21.28B | -2.54B | -20.20B | 13.16B |
| Net Change in Cash | 12.24B | -3.98B | -22.18B | 9.89B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | 22.7% | 24.0% | 25.6% | 26.7% |
| ROE % | 13.6% | 15.5% | 18.1% | 18.3% |
| ROCE % | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BBVA
BBVA completes the extraordinary share buyback program launched in December 2025 for nearly €4 billion - BBVA
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPLXBad1h3Qkc3bTRsemo4UENaSFUyUW1MZWdyN1hTWTE4NjA1QzF3LUk2MkN3VzdCNF9yZS1KdEkzbU9vWkJNMFVQNFU1WFhtM3RQODRlc1BoY292ajVlVzBVY05nb3FkcEtPVWc0Y2FaeWp1Tk1ESVJreXBSVXktSElCdUdGR3BnQkRJV1…
BBVA (BME:BBVA) Stock Rallies Behind Loan Growth And Fresh Buybacks - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFAxVjhEODRJVVZremYydXV0V21rZjBjTHFKSG0zNVhUTUlKOW1ram81T1JtejZ0Rzc4RUpRTjJrNWNBTVVUbXRpcm8tLXlKWXdfcTdpcW5KeFI?oc=5" target="_blank">BBVA (BME:BBVA) Stock Rallies Behind Loan Growth…
BBVA (BME:BBVA) Stock Trades Like A Bargain On Its 428% Run - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQbXJNWTNidmpiaXp5WVJqTnYwU19qUWZqUHpSV2FKNEJZRkhWWHh5cDRxSEpUYk41ZzNSeFg4eDhYeEUyczlVSldNU0N3dS1LbkJzU0NtaE4zWjFTTFREX0xkeDJqZFhKeVdQNGV5R3ZsYzktakdpUDFYbExraWVwNTZXYjYzWmYwQmhoX3…
(BBVA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNemw5QVZfeHhMUHp1empSTXVOV1ppaWhqNDJhMUdUbnhUWmtoTFdtbzd1RERvWWdJWTZMMWRYMHR5enFKa3dPc0xudW9Nd1czdEVNZUZYdmgwcmxBSGl3YVFxOXNSd0hwd3BoZE82MG9iSktTd045QUJBWVFYNHlseWdPUUxvUzByM1lNZj…
BBVA Lifts H1 2026 Profit Above €6 Billion and Launches New €2 Billion Buyback - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMi_gFBVV95cUxONTUyYTdSMnRWSXJkek01S2pZWXRzZkxxcGJqS3pleDNIYU9mcHluWmhlSXJiTm9NNUFVc3diVlZRSzVBby1ZNy13SU9hZEV2QnlDYjdEcVNfLUdoUVNDNXBjVDJVdVZXeUttaGpaYm92WHp3bEZkWTFGemVtaEh2QVRCVV80VDN3eXlFeF…
5 Finance Stocks Growing Faster than Tech - Benzinga
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPZEpid1NSLTlXNF9qTEhqMUhMSkdocl9NZ2lOQVVvRi16Yi1wM3pPOF90dnMxM0FvWXc2d3BRWFBIVUFtOE11QmlVOUNUNGlJaEVXc3VKc09JakxCYkR2VUNSNEM3YzhkWXhoakNJdFduQ1BTVDFnZE9wVTlLQ3NZbjA2TW9jV1V3SkttdT…
BBVA — Frequently Asked Questions
What is the current share price of BBVA?
As of 2026-08-05 17:25 PDT, BBVA trades at $28.07 on NASDAQ/NYSE. Its 52-week range is $16.25 to $28.36.
What is the market capitalisation of BBVA?
BBVA has a market capitalisation of $160.25B on NASDAQ/NYSE.
What is the P/E ratio of BBVA?
BBVA trades at a trailing price-to-earnings (P/E) ratio of 15.95. Its price-to-book (P/B) ratio is 2.79.
What is the return on equity (ROE) of BBVA?
BBVA has a return on equity (ROE) of 18.33%.
Is BBVA a good stock to buy?
This page provides a data-driven analysis of BBVA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.